Aspirin/paracetamol/caffeine

Aspirin/paracetamol(acetaminophen)/caffeine is a combination drug for the treatment of pain, especially tension headache and migraine.[1] It is sold in the US under the trade names Goody's Powder and Excedrin, although not all products sold under the Excedrin brand contain this combination. It is sold as Anadin Extra in the UK.

Aspirin/paracetamol/caffeine
Combination of
AspirinNSAID
ParacetamolAnalgesic
CaffeineStimulant
Clinical data
Trade namesExcedrin, Vanquish, others
AHFS/Drugs.comexcedrin
Routes of
administration		Oral
ATC code
Legal status
Legal status
Identifiers
PubChem CID
ChemSpider
Chemical and physical data
3D model (JSmol)

Adverse effects

The recommended dosing has a low risk profile when taken occasionally in a well hydrated state. As with all medications containing paracetamol (acetaminophen), concomitant use with alcohol carries a significant risk of hepatotoxicity. The combination of paracetamol with aspirin also creates the risk of renal papillary necrosis if large doses are taken chronically. This is because paracetamol yields a toxic metabolite that can accumulate in the kidney while aspirin works to deplete the glutathione stores necessary to oxidize it. Additionally, chronic aspirin usage is associated with increased risk of gastrointestinal bleeding.[2]

Chemical detection

The combination of these three compounds can be detected in pharmaceutical formulations, urine and blood serum in trace quantities using electrochemical methods.[3]

Other trade names

The combination was introduced in 1964 under the trade name Vanquish by Sterling Drug, which after a series of mergers and acquisitions became a unit of Bayer AG.

In Germany, it is sold as Chephapyrin, dolomo, Dolopyrin, HA-Tabletten N, Melabon, Neuralgin, Novo Petrin, ratiopyrin, Thomapyrin Classic, Thomapyrin Intensiv, Titralgan, in Austria as Thomapyrin, InfluASS, Irocophan, in Israel as Acamol Focus and in Russia as Citramon.

References
  1. Drugs.com: excedrin
  2. Henrich, W; Lawrence E. Agodoa; Brendan Barrett; William M. Bennett; Roland C. Blantz; Vardaman M. Buckalew Jr; Vivette D. D'Agati; Marc E. DeBroe; Geoffrey G. Duggin; Garabed Eknoyan; Monique M. Elseviers; R.Ariel Gomez; Gary R. Matzke; George A. Porter; Sandra Sabatin; Jeffrey S. Stoff; Gary E. Striker; James F. Winchester (1996). "Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc Committee of the National Kidney Foundation". American Journal of Kidney Diseases. 27: 162–165. doi:10.1016/S0272-6386(96)90046-3.
  3. Sanghavi, BJ; Srivastava, AK (2010). "Simultaneous voltammetric determination of acetaminophen, aspirin and caffeine using an in situ surfactant-modified multiwalled carbon nanotube paste electrode". Electrochimica Acta. 55 (28): 8638–48. doi:10.1016/j.electacta.2010.07.093.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.